Salivary Gland Carcinoma
11 clinical trials · Condition
◉ Watch Salivary Gland Carcinoma
| Record | Firm | Date |
|---|---|---|
| Intensity Modulated Proton or X-Ray Therapy After Surgery for Treatment of Head and Neck Cancer, the HEADLIGHT Study (NCT05075980) | Mayo Clinic | 2022-02-16 |
| Androgen Deprivation Therapy (ADT) and Pembrolizumab for Advanced Stage Androgen Receptor-positive Salivary Gland Carcinoma (NCT03942653) | Manish Patel | 2019-05-30 |
| Nivolumab and Ipilimumab and Stereotactic Body Radiation Therapy in Treating Patients With Salivary Gland Cancers (NCT03749460) | University of Washington | 2019-01-15 |
| Nivolumab in Recurrent or Metastatic Salivary Gland Carcinoma of the Head and Neck (NCT03132038) | UNICANCER | 2017-03-24 |
| Cell-free Tumor DNA in Head and Neck Cancer Patients (NCT03942380) | Christian von Buchwald | 2017-02-01 |
| Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158) (NCT02628067) | Merck Sharp & Dohme LLC | 2015-12-18 |
| Pazopanib in Patients With Progressive Recurrent and/or Metastatic Salivary Gland Carcinoma (NCT02393820) | UNICANCER | 2013-08-26 |
Track Salivary Gland Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.